Clinical Trial Update: Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating testosterone undecanoate versus placebo on intrahepatic fat content in overweight/obese men with type 2 diabetes or prediabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease
• Hypogonadism Male
• Overweight Obesity
• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Alexandra Kautzky-Willer | Conditions: Fatty Liver, Overweight/Obesity | Phase 4 | Status: RECRUITING